Viewing Study NCT00261092


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-04-06 @ 1:17 AM
Study NCT ID: NCT00261092
Status: COMPLETED
Last Update Posted: 2008-04-15
First Post: 2005-12-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: GEMOX: Oxaliplatin in Pancreatic Cancer
Sponsor: Sanofi
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: PM_L_0126
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators